Michael W. Drazer
University of Chicago Medicine
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (8)
Expansion of cDC cells via FLT3 agonism has promising therapeutic potential in the treatment of advanced solid tumors. Here, we discuss the results of a clinical trial using GS-3583, an FLT3 agonist, that was stopped after a patient in the study developed acute myeloid leukemia.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Collaborators (6)
Belinda Phipson
Lab head
Walter and Eliza Hall Institute of Medical Research
AUSTRALIA
Claire Homan
University of South Australia
AUSTRALIA
Kai Yu
National Human Genome Research Institute
UNITED STATES
Gregory Roloff
University of Chicago
UNITED STATES
Christopher Hahn
University of South Australia
AUSTRALIA
David Lawrence
University of South Australia
AUSTRALIA
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.